Conference Coverage
Conference Coverage
Fixed-duration venetoclax-obinutuzumab superior to standard CLL therapy
CHICAGO – The immediately practice changing study offers a time-limited frontline option, one expert reported.
Conference Coverage
Pembrolizumab improves 5-year OS in advanced NSCLC
CHICAGO – In a phase 1b trial of pembrolizumab, the 5-year OS rate was 23.2% in treatment-naive patients and 15.5% in previously treated patients...
Conference Coverage
Pain coping skills training doesn’t improve knee arthroplasty outcomes
TORONTO – A high level of pain catastrophizing prior to scheduled knee arthroplasty is not, as previously thought, a harbinger of poor outcomes....
Conference Coverage
Pazopanib extended PFS in patients with carcinoid tumors
CHICAGO – Significant efficacy results need to be viewed in light of increased toxicity.
Conference Coverage
Nephrectomy may benefit select renal cancer patients based on risk factors
CHICAGO – CARMENA update confirms cytoreductive nephrectomy should not be standard of care for most cases of metastatic renal cell carcinoma.
Conference Coverage
DOACs surpass warfarin in low-weight AFib patients
SAN FRANCISCO – Data from 21,000 Korean AFib patients weighing 60 kg or less showed DOACs had better efficacy and safety than did warfarin.
Conference Coverage
More liberal criteria could greatly expand clinical trial participation
CHICAGO – A proof-of-concept study suggests that broader inclusion criteria could nearly double participation in clinical trials for non–small...
Video
Developing new measurements for better MS outcomes
SEATTLE – Researchers are working on developing more sensitive ways of measuring MS disease status.
Conference Coverage
Laparoscopic surgery survival outcomes on par with open approach in colorectal liver metastases
CHICAGO – More centers should develop expertise in laparoscopic approach, investigator says.
Conference Coverage
Asymptomatic gallstones seldom require surgical intervention
SAN DIEGO – Patient variables that increased the need for surgical intervention included obesity and having a hemolytic disorder.